Autopsy report · NCT04129515

NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Contract Issues”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 1, Phase 2
Sponsor: Brown University
Sponsor type: University, hospital or other
Conditions: Metastatic Melanoma; Melanoma Brain Metastasis
Interventions: NovoTTF-200A; Pembrolizumab
Participants: 0
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.